Brief: Calithera Biosciences And Antengene Enter Worldwide License Agreement For Development & Commercialization Of Cb-708

Calithera Biosciences

17/05/2021 13:55

May 17 (Reuters) - Antengene Corporation Ltd  6996.HK :
    * CALITHERA BIOSCIENCES AND ANTENGENE ENTER WORLDWIDE
LICENSE AGREEMENT FOR DEVELOPMENT & COMMERCIALIZATION OF CB-708
    * CALITHERA BIOSCIENCES INC -  UNDER AGREEMENT, WILL RECEIVE
UPFRONT PAYMENT AND POTENTIAL DEVELOPMENT, REGULATORY, SALES
MILESTONES OF UP TO $255.0 MILLION
    * CALITHERA BIOSCIENCES INC -  UNDER AGREEMENT, ANTENGENE
INVESTMENT LTD WILL RECEIVE EXCLUSIVE, WORLDWIDE RIGHTS TO
DEVELOP AND COMMERCIALIZE CB-708

Source text for Eikon:  ID:nGNX4LVgFk 
Further company coverage:  6996.HK 

 ((Reuters.Briefs@thomsonreuters.com;))